Zai Lab (1ZL) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1ZL Analyst Ratings

Strong Buy

3 Buy

0 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Zai

Lab

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1ZL Stock 12 Month Forecast

Average Price Target

€33.95

▲(54.31% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Zai Lab in the last 3 months. The average price target is €33.95 with a high forecast of €38.84 and a low forecast of €31.07. The average price target represents a 54.31% change from the last price of €22.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"€12","39":"€39","18.75":"€18.75","25.5":"€25.5","32.25":"€32.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.83967775,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€38.84</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33.94875536666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€33.95</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.0717422,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€31.07</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,18.75,25.5,32.25,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,17.387667519230767,19.175335038461537,20.963002557692306,22.750670076923075,24.538337596153845,26.326005115384614,28.113672634615384,29.901340153846153,31.689007673076922,33.47667519230769,35.26434271153846,37.05201023076923,{"y":38.83967775,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,17.01144272051282,18.42288544102564,19.834328161538462,21.245770882051282,22.657213602564102,24.068656323076922,25.480099043589743,26.891541764102563,28.302984484615383,29.714427205128203,31.125869925641023,32.53731264615384,{"y":33.94875536666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,16.790134015384616,17.98026803076923,19.170402046153846,20.36053606153846,21.550670076923076,22.74080409230769,23.930938107692306,25.12107212307692,26.311206138461536,27.50134015384615,28.69147416923077,29.881608184615384,{"y":31.0717422,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":32.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.3,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€38.84

Average Price Target€33.95

Lowest Price Target€31.07

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anupam Rama

J.P. Morgan

€23.3→€31.07

Buy

41.24%

Upside

Assigned

08/27/26

Zai Lab price target raised to $36 from $27 at JPMorganZai Lab price target raised to $36 from $27 at JPMorgan

Yigal Nochomovitz

Citi

€37.98→€38.84

Buy

76.54%

Upside

Reiterated

08/06/26

Zai Lab price target raised to $45 from $44 at CitiZai Lab price target raised to $45 from $44 at Citi

Li Watsek

Cantor Fitzgerald

€31.93

Buy

45.16%

Upside

Reiterated

08/06/26

Analysts Are Bullish on These Healthcare Stocks: Zai Lab (ZLAB), CG Oncology, Inc. (CGON)

David Li

Bank of America Securities

€18.82→€18.64

Hold

-15.26%

Downside

Reiterated

05/21/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Zai Lab (NASDAQ: ZLAB) and NanoViricides (NYSE MKT: NNVC)

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

€37.04→€31.93

Buy

45.12%

Upside

Reiterated

01/15/26

Zai Lab (ZLAB) Receives a Buy from Goldman Sachs

Michael Yee

UBS

€30.21

Buy

37.31%

Upside

Initiated

01/07/26

Zai Lab initiated with a Buy at UBSZai Lab initiated with a Buy at UBS

Jonathan Chang

Leerink Partners

€63.87

Buy

190.32%

Upside

Reiterated

10/21/25

Leerink Partners Sticks to Their Buy Rating for Zai Lab (ZLAB)

Jack Lin

Morgan Stanley

€44.88→€41.43

Buy

88.31%

Upside

Reiterated

09/21/25

Analysts Offer Insights on Healthcare Companies: United Therapeutics (NASDAQ: UTHR) and Zai Lab (NASDAQ: ZLAB)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anupam Rama

J.P. Morgan

€23.3→€31.07

Buy

41.24%

Upside

Assigned

08/27/26

Zai Lab price target raised to $36 from $27 at JPMorganZai Lab price target raised to $36 from $27 at JPMorgan

Yigal Nochomovitz

Citi

€37.98→€38.84

Buy

76.54%

Upside

Reiterated

08/06/26

Zai Lab price target raised to $45 from $44 at CitiZai Lab price target raised to $45 from $44 at Citi

Li Watsek

Cantor Fitzgerald

€31.93

Buy

45.16%

Upside

Reiterated

08/06/26

Analysts Are Bullish on These Healthcare Stocks: Zai Lab (ZLAB), CG Oncology, Inc. (CGON)

David Li

Bank of America Securities

€18.82→€18.64

Hold

-15.26%

Downside

Reiterated

05/21/26

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Zai Lab (NASDAQ: ZLAB) and NanoViricides (NYSE MKT: NNVC)

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

€37.04→€31.93

Buy

45.12%

Upside

Reiterated

01/15/26

Zai Lab (ZLAB) Receives a Buy from Goldman Sachs

Michael Yee

UBS

€30.21

Buy

37.31%

Upside

Initiated

01/07/26

Zai Lab initiated with a Buy at UBSZai Lab initiated with a Buy at UBS

Jonathan Chang

Leerink Partners

€63.87

Buy

190.32%

Upside

Reiterated

10/21/25

Leerink Partners Sticks to Their Buy Rating for Zai Lab (ZLAB)

Jack Lin

Morgan Stanley

€44.88→€41.43

Buy

88.31%

Upside

Reiterated

09/21/25

Analysts Offer Insights on Healthcare Companies: United Therapeutics (NASDAQ: UTHR) and Zai Lab (NASDAQ: ZLAB)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zai Lab

3 Months

Jonathan ChangLeerink Partners

Success Rate

16/40 ratings generated profit

Average Return

-3.26%

Copying Jonathan Chang's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -3.26% per trade.

1 Year

Jonathan ChangLeerink Partners

Success Rate

14/40 ratings generated profit

Average Return

+1.07%

Copying Jonathan Chang's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of +1.07% per trade.

2 Years

Jonathan ChangLeerink Partners

Success Rate

8/40 ratings generated profit

Average Return

+7.96%

Copying Jonathan Chang's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of +7.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ZL Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1ZL has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1ZL average Analyst price target in the past 3 months is 33.95.

Each month's total comprises the sum of three months' worth of ratings.

1ZL Financial Forecast

1ZL Earnings Forecast

Next quarter’s earnings estimate for 1ZL is -€0.48 with a range of -€0.57 to -€0.42. The previous quarter’s EPS was -€0.43. 1ZL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ZL has Performed in-line its overall industry.

1ZL Sales Forecast

Next quarter’s sales forecast for 1ZL is €93.36M with a range of €90.07M to €96.33M. The previous quarter’s sales results were €91.35M. 1ZL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ZL has Performed in-line its overall industry.

1ZL Stock Forecast FAQ

What is DE:1ZL’s average 12-month price target, according to analysts?

Based on analyst ratings, Zai Lab’s 12-month average price target is 33.95.

What is DE:1ZL’s upside potential, based on the analysts’ average price target?

Zai Lab has 54.31% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Zai Lab a Buy, Sell or Hold?

Zai Lab has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.

What is Zai Lab’s share price target?

The average share price target for Zai Lab is 33.95. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €38.84 ,and the lowest forecast is €31.07. The average share price target represents 54.31% Increase from the current price of €22.

What do analysts say about Zai Lab?

Zai Lab’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of Zai Lab?

To buy shares of DE:1ZL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Zai Lab (1ZL) Stock Forecast & Price Target

1ZL Analyst Ratings

1ZL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zai Lab

1ZL Analyst Recommendation Trends

1ZL Financial Forecast

1ZL Earnings Forecast

1ZL Sales Forecast

1ZL Stock Forecast FAQ

Detailed List of Analyst Forecasts